Tag: vitamin K antagonist

Vitamin and supplement data remains limited, may provide no benefit

Rivaroxaban does not prevent cardiovascular events in rheumatic heart disease patients with atrial fibrillation

byBryant Limand1 others

September 15, 2022

1. Rivaroxaban was not associated with a lower rate of cardiovascular events and death compared to vitamin K antagonist treatment ...

#VisualAbstract Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in patients with non-valvular atrial fibrillation

byKathleen Lau

August 12, 2021

#VisualAbstract: Azithromycin does not improve clinical outcomes in high-risk patients with suspected COVID-19 in the community setting

#VisualAbstract: Direct oral anticoagulants may be the superior treatment for patients with atrial fibrillation on dialysis

byConstance Wu

April 6, 2021

1. Direct oral anticoagulants may have a superior risk-benefit profile compared to vitamin K antagonists in atrial fibrillation for patients ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: vitamin K antagonist

Rivaroxaban does not prevent cardiovascular events in rheumatic heart disease patients with atrial fibrillation

#VisualAbstract Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in patients with non-valvular atrial fibrillation

#VisualAbstract: Direct oral anticoagulants may be the superior treatment for patients with atrial fibrillation on dialysis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports